Lanacane

Quick links to important sections

Lanacane

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lanacane

Property Description
Active Ingredient Benzocaine (Ethyl p-aminobenzoate)
Form Medicated Cream, Topical Spray
Pharmacological Class Local Anesthetic (Surface/Topical Anesthetic)
Common Use Provides temporary, localized relief from skin discomfort
Origin Synthetic (Amino Ester Compound)

Lanacane: Definition and Pharmaceutical Classification

Lanacane is an over-the-counter topical preparation that contains Benzocaine as its active compound. Benzocaine is classified pharmacologically as a topical anesthetic and is a synthetic molecule belonging to the amino ester class of local anesthetics. Its effectiveness in blocking nerve signals is recognized for temporary surface application.

The medication is defined as a surface anesthetic because its intended action is strictly localized to the area of application, without requiring systemic absorption. Benzocaine is an agent used to numb the skin and surfaces, functioning as an external desensitizer.

Composition and Topical Formulations

Lanacane is manufactured for topical administration, primarily available as a medicated cream or a topical spray, which are standard forms for delivering superficial numbing agents. The product is typically a single active ingredient product, with the Benzocaine incorporated into a stable cream base or solution.

The choice of topical dosage form ensures that the active ingredient is concentrated precisely on the skin's surface to maximize contact with sensory nerve endings. This composition defines the medication's intended use as an external skin treatment, providing localized relief.

Core Action and General Purpose

The general purpose of this topical preparation is to provide fast-acting, localized relief from skin discomfort, such as the temporary itching and irritation that accompanies minor skin issues. This effect is achieved through Benzocaine's function as a sodium channel blocker.

By temporarily binding to specific sodium channels on sensory nerve membranes, Benzocaine performs nerve impulse inhibition, which is the physiological basis of anesthesia. This process prevents the local transmission of pain and itch signals at the application site, defining the product's role as a temporary external analgesic.

What side effects are possible with Lanacane?

Possible Side Effects and Safety Information

The regulatory safety profile of topical Benzocaine, the active ingredient in Lanacane, is formally documented by government authorities and categorized into localized skin reactions and a rare systemic blood disorder risk.

Systemic Serious Adverse Reaction

The most critical safety consideration is the documented risk of Methaemoglobinaemia (methemoglobinemia), a serious, potentially life-threatening condition classified under Blood and Lymphatic System Disorders. This condition impairs the blood's ability to carry oxygen. Regulatory documents describe symptoms that may indicate this adverse reaction, including a pale, gray, or blue-colored appearance of the skin, lips, and nail beds, alongside shortness of breath, headache, and rapid heart rate.

Dermatological Adverse Reactions

Side effects categorized as Skin and Subcutaneous Tissue Disorders are common and are generally localized to the application site. These include local irritation such as a burning or stinging sensation. Signs of hypersensitivity, often classified as having an unknown or uncommon frequency, include allergic contact dermatitis, which may manifest as itching, redness (erythema), or localized swelling (edema).

Population-Specific Constraints

Official safety communications highlight that infants and children under two years of age are at a significantly higher risk for developing methaemoglobinaemia. Increased risk also applies to adults with pre-existing conditions such as heart disease or underlying breathing problems. The product should not be applied to large areas of skin, broken or severely irritated skin, or used for prolonged periods, as these factors increase the potential for systemic exposure and the risk of serious adverse effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Lanacane, which contains the local anesthetic Benzocaine, emphasizes the risk of Methemoglobinemia following overdose or excessive systemic absorption. This condition is the most serious documented manifestation and can be life-threatening.

Documented Manifestations and Serious Outcomes

Symptoms indicative of Methemoglobinemia are explicitly listed in regulatory documents and include a noticeable pale, gray, or blue discoloration of the skin, lips, or nail beds (cyanosis). Other clinical signs associated with reduced oxygen transport include shortness of breath, fatigue, severe headache, confusion, and a rapid heart rate (tachycardia). Overdose or high systemic exposure, such as applying too much product or use on irritated skin, may result in cardiovascular collapse or death.

Emergency Actions and High-Risk Populations

Immediate medical attention must be sought if any signs or symptoms suggestive of Methemoglobinemia are observed after using this product. Users must discontinue use immediately. Regulatory authorities have identified infants and children under 2 years of age as a high-risk group due to their increased susceptibility to severe complications. In confirmed cases of Methemoglobinemia, treatment, as described in regulatory documentation, often involves the administration of the specific medication, Methylene blue, along with necessary supportive care and close monitoring.

Therapeutic Uses of Lanacane

What Lanacane Treats: Main Uses and Benefits

Lanacane, whose main active ingredient is the local anesthetic benzocaine, is commonly used for short-term symptomatic assistance in situations involving certain symptoms related to physical discomfort. The medication is applied in addressing the pain and itching that may arise from minor burns, scrapes, and insect bites.

This active ingredient is considered relevant for easing discomfort associated with temporary skin irritations. As a topical local anesthetic, benzocaine plays a role in managing physical discomfort, which contributes to improved comfort during periods of heightened symptoms. This may assist with providing supportive relief in situations where symptoms interfere with routine activities and is relevant for easing irritation and minor discomfort.

It is applied when appropriate in contexts involving acute or disruptive symptom patterns affecting the skin, helping to manage symptom clusters that may become intense or disruptive. The support helps maintain a sense of stability when symptoms are more noticeable.

“The product may help patients cope more steadily with symptom fluctuations during episodes of heightened discomfort.”

Benefit: Supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lanacane (Topical Benzocaine)

The eligibility for using Lanacane, which contains the local anesthetic benzocaine, is strictly defined by regulatory warnings, primarily focusing on age and specific pre-existing conditions.

Contraindicated Populations

The medicine is contraindicated and must not be used in children younger than 2 years of age. This absolute prohibition is based on the significantly elevated risk of methemoglobinemia in this pediatric group. Use is also strictly prohibited for individuals with a known hypersensitivity or allergy to benzocaine, other ester-type anesthetics, or PABA.

Restricted and High-Risk Use

Use requires caution in several high-risk populations, including older adults and patients with underlying conditions such as heart disease or respiratory problems (e.g., asthma, emphysema), due to the greater risk of methemoglobinemia complications. The product should also not be applied to large, sore, broken, or inflamed skin to prevent excessive systemic absorption.

Pregnancy and Lactation Eligibility

Topical benzocaine is classified as Pregnancy Category C, meaning use is conditional and recommended only when the benefit is determined to outweigh the risk. During lactation, application to the breast or nipple area is prohibited to prevent infant exposure.

What should I know about interactions with other medicines?

The interaction profile for the active ingredient in Lanacane, topical Benzocaine, is defined by an officially documented pharmacodynamic interaction that involves an additive risk of methemoglobin formation. This interaction is classified by regulatory authorities as highly clinically significant. The profile is not structured around metabolic (CYP) or transporter-mediated interactions, as these are not documented in official labeling for the topical formulation.

The risk of methemoglobinemia can be increased when topical Benzocaine is co-administered with other agents known to cause this condition. Specific medicinal products cited in regulatory documentation include Dapsone and various Nitrate derivatives, such as nitroglycerin. The official profile also extends this caution to non-medicinal substances, noting that the ingestion of nitrites and nitrates found in certain foods and water may contribute additively to this toxicological risk. No timing-based rules requiring separation from other medications are specified in the official labeling.

Regulatory safety communications emphasize that the interaction’s potential severity is greater in specific patient populations. Individuals with underlying conditions that affect oxygen-carrying capacity, such as G6PD deficiency, NADH-methemoglobin reductase deficiency, or pyruvate-kinase deficiency, are identified as having heightened susceptibility. Patients with existing heart disease or respiratory compromise are also included in the interaction-context constraints due to increased vulnerability to the effects of reduced oxygen in the blood.

Mechanism of Action

Voltage-Gated Sodium Channel Blockade

The primary mechanism involves the active component, Benzocaine, targeting and binding to the voltage-gated sodium channels ( Na v channels) located on peripheral sensory nerve membranes. This interaction is a non-competitive blockade that physically obstructs the channel's pore, preventing the necessary influx of sodium ions ( Na^+) that initiates nerve signaling.


Interruption of Peripheral Sensory Signal Transmission

The molecular blockade initiates a cascade where the nerve membrane fails to achieve depolarization, leading to the suppression of the action potential (nerve impulse). This localized interruption of signal transduction restricts the transmission of nerve impulses from the periphery to the central nervous system. The physiological consequence is a targeted and temporary suppression of electrical excitability in the nerve endings at the application site.


Mechanistic Consequence: Localized Functional Suppression

As a strictly peripheral mechanism, the drug's action is confined to the immediate area of application, confining modulation to the localized area of application. The mechanism is entirely dependent on the drug's ability to diffuse through tissue to reach the nerve endings; consequently, the functional suppression of the nerve endings is transient and reversible as the molecule redistributes away from the target site.

Dosage and Administration Information

How to Use Lanacane

The administration of Lanacane, a product containing the local anesthetic Benzocaine, is governed by instructions that specify the correct route, frequency, and duration of use. These instructions are designed to provide a standardized approach to application as documented in standardized guidelines.


Administration Scope

Instruction Detail
Route of administration The medication is approved for Topical (External Skin Use) only.
Dosing schedule A small amount or thin layer should be applied to the affected external area. The amount should not exceed the smallest quantity needed for temporary relief.
Frequency and Schedule Application is symptom-driven, or as-needed, but must not occur more than 3 to 4 times daily.
Preparation requirements The topical spray formulation requires holding the container at a specific distance (e.g., 6 to 12 inches) during application. For facial use, the spray should be applied to the hand first and then transferred to the area, specifically avoiding the eyes.
Age-group administration Use is approved for Adults and children 2 years of age and older. Use in children under 2 years of age is generally not recommended without consultation.
Course Duration Use is strictly short-term. Application must be stopped if symptoms persist for more than 7 consecutive days.

Use Protocol Structure

The instructions establish a structured parameter for use. The overall protocol emphasizes external administration at a controlled, intermittent frequency.

Official procedural sequence principles:

  • Apply the topical preparation to the specific external area.
  • Adhere to the defined limit of no more than 3 to 4 applications within a 24-hour period.
  • Discontinue the product if symptoms persist beyond seven consecutive days of application.

These guidelines collectively define the regulated application method and time limits for self-medication, ensuring adherence to the product label.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Lanacane is a topical formulation containing Benzocaine, an ester-type local anesthetic. Research on the product's active ingredient focuses on its ability to temporarily block nerve impulses at the application site, thereby reducing the localized sensation of pain and itching.


Efficacy for Minor Skin Irritation

Clinical studies have explored the effect of topical Benzocaine in managing pain associated with minor skin conditions. Benzocaine is primarily indicated for the temporary relief of pain and itching from sunburn, minor burns, insect bites, scrapes, and other minor skin irritations.

  • Onset of Action: The temporary numbing effect typically begins rapidly following application. Research involving 10% Benzocaine ointments showed an onset of pain reduction within 20 minutes for mild sunburn pain.
  • Mechanism Focus: The evidence supports that the agent stabilizes the neuronal membrane, preventing the initiation and conduction of nerve impulses in the localized area of the skin.

Safety and Adverse Event Monitoring

Long-term studies examining the systemic safety profile of topical Benzocaine formulations are limited. Adverse event monitoring focuses on localized reactions, such as allergic dermatitis, burning, and stinging at the application site.

A significant safety concern documented by regulatory bodies involves the rare but serious blood disorder methemoglobinemia, which has been reported, particularly when high concentrations of Benzocaine sprays were applied to the mouth or mucous membranes, or when products were used inappropriately on infants and young children. Caution is advised when using Benzocaine on large areas of broken skin or for prolonged periods.

Frequently Asked Questions (FAQ)

Common questions about Lanacane (FAQ)

Q: Does Lanacane just stop the itch, or does it also help with the underlying problem?

A: The active ingredient in Lanacane is a local anesthetic intended to provide symptomatic relief from pain and itching. It works by temporarily blocking nerve signals at the application site. Official product information describes this action as transient, meaning it is not intended to treat the underlying cause of the irritation.


Q: Does Lanacane expire, and can I still use it after the expiration date?

A: Official instructions specify a required storage temperature to help maintain the stability of the product. Like all medications, Lanacane has an expiration date listed on the packaging. To ensure the product remains effective and compliant with regulatory standards, regulatory guidance states it should not be used after this date.


Q: What is the difference between Lanacane cream and Lanacane spray?

A: The product is available in different physical forms, such as a cream and a topical spray. Official product labels differentiate between these forms, sometimes listing varying concentrations or inactive ingredients. For example, the spray formulation has specific instructions regarding the distance from which it should be applied.


Q: Can I use Lanacane if I'm already taking pain relief medication?

A: The official interaction profile lists specific drug types, such as Dapsone and Nitrate derivatives, that may increase the risk of a serious blood disorder. Regarding co-administration with other medications, official labeling does not specify timing rules for separating applications of other medicines.


Q: Is Lanacane absorbed into the bloodstream after applying it to the skin?

A: Official information indicates that a small amount of the active ingredient may be absorbed into the bloodstream from the application site. The potential for this systemic absorption is known to increase if the product is used in large amounts, applied over large areas of the skin, or if the skin is broken.


Q: Can Lanacane be used to treat a rash that has blisters?

A: Official warnings advise against using the product on skin that is severely irritated, raw, or blistered. This constraint is in place because application to broken skin can increase the amount of medicine absorbed into the bloodstream.


Q: Is there a limit on the size of the area of skin Lanacane can be used on?

A: Regulatory warnings advise against using the product over large areas of the body. Applying the medication to an extensive area can significantly increase the potential for systemic exposure and side effects.


Q: What should I do if the irritation gets worse after using Lanacane?

A: The official label includes instructions to discontinue use if severe reactions occur. The label states that medical attention should be sought immediately if symptoms such as severe burning, stinging, increased sensitivity, swelling, or blistering develop in the treated area.


Q: Can Lanacane be used on the face?

A: The spray formulation has a specific application protocol for the face, which involves applying the product to the hand first and then transferring it to the intended area. This is primarily to ensure the product does not come into contact with the eyes.


Q: Is there a maximum amount of Lanacane that can be used safely over a week?

A: While the label does not state a hard weekly dosage limit, official guidelines specify that the maximum duration of use is not to exceed seven consecutive days without consulting a health professional. Additionally, the maximum daily frequency of application is restricted to three to four times a day.


Q: Is Lanacane the same as other anti-itch creams, or is there a difference?

A: Lanacane contains Benzocaine, which is a topical local anesthetic. This means it works by temporarily blocking nerve signals in the skin at the application site. Other anti-itch creams may contain different active ingredients, such as antihistamines or corticosteroids, which work through different mechanisms.


Q: Is Lanacane safe to use on sensitive skin areas?

A: Lanacane is described as being for external use on minor skin irritations. However, official safety profiles note that localized skin reactions, such as a burning or stinging sensation, can occur. The product can also potentially cause an allergic contact dermatitis reaction.


Q: Are there different strengths or types of Lanacane, and what are the differences?

A: The product is marketed in different forms, including creams and topical sprays. These different forms are generally listed in product labeling with varying concentrations of the active ingredient or differences in inactive ingredients.


Q: What should I do if I accidentally swallow a small amount of Lanacane?

A: The official label includes specific instructions for accidental ingestion. The label states the product should be kept out of reach of children and that, in case of overdose or accidental swallowing, immediate medical attention or contact with a Poison Control Center is necessary.


Q: Does Lanacane contain steroids?

A: Official regulatory databases and product labeling describe the active ingredient as Benzocaine, a local anesthetic. Steroids, such as hydrocortisone, are not listed as an active component of this medication.


Q: Can Lanacane be used during pregnancy or while breastfeeding?

A: The active ingredient, Benzocaine, has been assigned to Pregnancy Category C by the FDA. Regulatory warnings indicate that there is limited data available on the use of this product during pregnancy and its excretion into human milk. Official labeling indicates that use during pregnancy or breastfeeding is subject to the consideration that the potential benefit should outweigh the potential risk.


Q: Is Lanacane available over-the-counter, or do I need a prescription?

A: According to regulatory bodies, Lanacane is classified as a Nonprescription Drug, commonly referred to as over-the-counter (OTC). This means the product is available to patients without requiring a doctor's prescription.


Q: Are there any ingredients in Lanacane that could cause skin discoloration?

A: Official adverse event documentation notes side effects that include temporary changes to skin color, such as redness, or a pale, gray, or blue-colored appearance (symptoms of methemoglobinemia). Ingredients that cause permanent staining or discoloration are not typically listed in the standard adverse events documentation.


Q: What happens if I forget to apply a dose of Lanacane?

A: Official guidance on missed doses indicates that the dose is applied as soon as it is remembered. However, if the time is almost for the next scheduled dose, regulatory guidance suggests the missed dose be skipped to maintain the regular application schedule.


Q: Will Lanacane make me drowsy or affect my ability to drive?

A: Dizziness, lightheadedness, and unusual drowsiness or weakness are listed in the official safety profile. These symptoms are associated with the rare but serious side effect of methemoglobinemia or may occur in cases of overdose.


Q: Are there certain materials or clothing that interact badly with Lanacane?

A: Official warnings advise against covering the treated skin areas with a bandage or plastic wrap unless specifically advised by a health professional. This is because covering the area can increase the absorption of the medicine into the body.


Q: Why is it advised not to use Lanacane under bandages or tight dressings?

A: Regulatory warnings advise against covering the treated area with bandages, plastic wrap, or tight dressings. The reason for this caution is that covering the skin can significantly increase the amount of medicine absorbed into the body, which may increase the risk of side effects.


Q: Does Lanacane have any known interaction with alcohol consumption?

A: Direct regulatory labels do not typically list a specific interaction between topical Benzocaine and alcohol consumption.


Q: If I am using another topical medicine, should I space out the applications of Lanacane?

A: According to the official interaction profile, the labeling does not specify any timing-based rules that would require a patient to separate the applications of Lanacane and other topical medications.

How should Lanacane be stored and disposed of?

Storage and Protection Requirements

Lanacane, whose active ingredient is benzocaine, must be stored within a specific controlled room temperature range to maintain stability. The official required temperature is between 15 C and 30 C (59 F and 86 F). The product must be protected from environmental extremes, as regulatory guidance strictly mandates do not freeze and requires the container be kept away from excessive heat and moisture.

Child Safety and Handling

All forms of the medicine must be stored out of the reach and sight of children. If the cream or spray is accidentally swallowed, official labeling requires contacting a Poison Control Center immediately. For topical spray canisters, do not puncture the container or dispose of it in a fire, even when empty.

Disposal Instructions

Unused or expired medicine should preferably be disposed of through an authorized drug take-back program or collection site. If a take-back option is unavailable, the product may be discarded in the household trash only after being mixed with an unappealing substance, such as dirt or used coffee grounds, and then sealed in a separate container. Medicines must not be flushed down the toilet or poured into the sink unless explicitly instructed by official labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lanacane found in:

A-Z Index: